CONMED Corporation (CNMD) Insider Trading Activity
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
CNMD Insider Trading Activity
CNMD Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $97,322 | 1 | 25 |
Sells | $531,844 | 3 | 75 |
Related Transactions
| BRONSON DAVID M | director | 1 | $97,322 | 0 | $0 | $97,322 |
| Glaze Richard | Chief Information Officer | 0 | $0 | 1 | $16,796 | $-16,796 |
| Farkas Charles | director | 0 | $0 | 1 | $227,768 | $-227,768 |
| Peters Stanley W III | President AS and AET | 0 | $0 | 1 | $287,280 | $-287,280 |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Insider Activity of CONMED Corporation
Over the last 12 months, insiders at CONMED Corporation have bought $97,322 and sold $531,844 worth of CONMED Corporation stock.
On average, over the past 5 years, insiders at CONMED Corporation have bought $544,054 and sold $19.1M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BRONSON DAVID M (director) — $97,322.
The last purchase of 1,350 shares for transaction amount of $97,322 was made by BRONSON DAVID M (director) on 2024‑05‑13.
List of Insider Buy and Sell Transactions, CONMED Corporation
| 2025-05-05 | Sale | Farkas Charles | director | 4,000 0.0129% | $56.94 | $227,768 | +1.13% | |
| 2025-02-11 | Sale | Glaze Richard | Chief Information Officer | 257 0.0008% | $65.35 | $16,796 | -9.24% | |
| 2024-06-14 | Sale | Peters Stanley W III | President AS and AET | 4,000 0.0125% | $71.82 | $287,280 | -4.63% | |
| 2024-05-13 | BRONSON DAVID M | director | 1,350 0.0043% | $72.09 | $97,322 | -5.75% | ||
| 2024-05-08 | Schwarzentraub Barbara J | director | 1,442 0.0047% | $69.26 | $99,873 | -0.66% | ||
| 2024-05-06 | Aronson Martha Goldberg | director | 2,000 0.0065% | $70.98 | $141,960 | -2.40% | ||
| 2024-04-30 | Beyer Pat | Chief Operating Officer | 3,000 0.0098% | $68.30 | $204,900 | +1.76% | ||
| 2023-12-04 | Sale | Peters Stanley W III | President AS and AET | 2,300 0.0074% | $109.93 | $252,833 | -32.97% | |
| 2023-11-07 | Sale | Peters Stanley W III | President AS and AET | 1,200 0.004% | $102.39 | $122,874 | -24.87% | |
| 2023-09-13 | Sale | Peters Stanley W III | President AS and AET | 2,000 0.0065% | $107.31 | $214,629 | -25.28% | |
| 2023-08-16 | Sale | Garner Todd W | Executive Vice President & CFO | 1,355 0.0045% | $112.00 | $151,760 | -23.56% | |
| 2023-06-15 | Sale | Hartman Curt R | President, CEO and Chair | 1,000 0.0033% | $136.00 | $136,000 | -26.81% | |
| 2023-06-08 | Sale | Ferrell John D. | Executive Vice President - HR | 1,700 0.0056% | $131.81 | $224,077 | -23.39% | |
| 2023-06-08 | Sale | Peters Stanley W III | VP GM Advanced Surgery | 5,000 0.0163% | $131.14 | $655,676 | -23.39% | |
| 2023-06-07 | Sale | CONCANNON BRIAN | director | 812 0.0027% | $129.01 | $104,756 | -21.12% | |
| 2023-05-22 | Sale | Peters Stanley W III | VP GM Advanced Surgery | 1,500 0.0049% | $120.89 | $181,343 | -13.18% | |
| 2023-05-18 | Sale | Peters Stanley W III | VP GM Advanced Surgery | 1,500 0.0049% | $119.24 | $178,861 | -10.78% | |
| 2023-05-01 | Sale | CONCANNON BRIAN | director | 2,072 0.0067% | $125.00 | $259,000 | -14.42% | |
| 2023-04-28 | Sale | Pelletier Johonna Marie | Treasurer and VP, Tax | 8,717 0.0288% | $126.53 | $1.1M | -14.05% | |
| 2023-04-28 | Sale | Jonas Daniel S | Special Counsel & Corp Secy | 10,000 0.0329% | $126.10 | $1.26M | -14.05% |
Insider Historical Profitability
| BRONSON DAVID M | director | 16460 0.0532% | $988,423.00 | 2 | 0 | <0.0001% |
| Farkas Charles | director | 16346 0.0528% | $981,577.30 | 12 | 1 | +4.46% |
| Peters Stanley W III | President AS and AET | 63 0.0002% | $3,783.15 | 0 | 18 | |
| Glaze Richard | Chief Information Officer | 0 0% | $0 | 0 | 1 | |
| CORASANTI JOSEPH J | Former President & CEO | 156356 0.5054% | $9.39M | 0 | 38 | |
| CORASANTI EUGENE R | director | 77058 0.2491% | $4.63M | 0 | 53 | |
| SHALLISH ROBERT D JR | EVP, Finance, CFO | 53915 0.1743% | $3.24M | 2 | 12 | +8.8% |
| STOTTS JOHN J | VP PATIENT CARE | 27001 0.0873% | $1.62M | 0 | 1 | |
| Cohen Heather L | EVP CORP HR | 24456 0.079% | $1.47M | 3 | 17 | +31.36% |
| Workman John L | director | 16035 0.0518% | $962,901.75 | 3 | 0 | <0.0001% |
| Jones Gregory Renard | EVP-Corporate QA/RA | 15367 0.0497% | $922,788.35 | 0 | 4 | |
| Snyder Mark D | EVP Mfg. Ops & Business System | 14262 0.0461% | $856,433.10 | 0 | 1 | |
| Jonas Daniel S | Special Counsel & Corp Secy | 13462 0.0435% | $808,393.10 | 1 | 40 | <0.0001% |
| Darling Joseph G | EVP, Commercial Operations | 12015 0.0388% | $721,500.75 | 0 | 6 | |
| Beyer Pat | Chief Operating Officer | 10807 0.0349% | $648,960.35 | 2 | 2 | <0.0001% |
| KENNEDY JOHN JED | Group Executive Vice President | 9855 0.0319% | $591,792.75 | 0 | 9 | |
| CONCANNON BRIAN | director | 9335 0.0302% | $560,566.75 | 0 | 4 | |
| TRYNISKI MARK E | director | 8296 0.0268% | $498,174.80 | 2 | 3 | +40.93% |
| GOLDEN JO ANN | director | 7782 0.0252% | $467,309.10 | 0 | 14 | |
| SCHWARTZ STUART J | director | 7400 0.0239% | $444,370.00 | 0 | 11 | |
| DANIELS BRUCE | director | 5000 0.0162% | $300,250.00 | 0 | 15 | |
| Kuyper Dirk | director | 5000 0.0162% | $300,250.00 | 1 | 5 | +37.5% |
| WILLIAMS FRANK R | VICE PRESIDENT | 4926 0.0159% | $295,806.30 | 0 | 9 | |
| MATTHEWS WILLIAM | director | 4500 0.0145% | $270,225.00 | 0 | 6 | |
| Hartman Curt R | President, CEO and Chair | 4299 0.0139% | $258,154.95 | 4 | 10 | +10.15% |
| Ruiz-Caban Wilfredo | EVP QA, RA and Operations | 3951 0.0128% | $237,257.55 | 0 | 1 | |
| ACEY THOMAS | SECRETARY & TREASURER | 3375 0.0109% | $202,668.75 | 0 | 10 | |
| Lande Jerome J. | 2407 0.0078% | $144,540.35 | 0 | 2 | ||
| JONES ALEXANDER | VP CORPORATE SALES | 2292 0.0074% | $137,634.60 | 0 | 1 | |
| Aronson Martha Goldberg | director | 2000 0.0065% | $120,100.00 | 1 | 0 | |
| SHAGORY PETER K | EVP, STRAT & CORP DEVT | 1861 0.006% | $111,753.05 | 0 | 9 | |
| Folkert Nathan | VP GM Orthopedics | 1600 0.0052% | $96,080.00 | 0 | 2 | |
| ABRAHAM WILLIAM | EVP-Business Development | 1486 0.0048% | $89,234.30 | 0 | 26 | |
| Schwarzentraub Barbara J | director | 1442 0.0047% | $86,592.10 | 1 | 1 | |
| Pelletier Johonna Marie | Treasurer and VP, Tax | 1317 0.0043% | $79,085.85 | 0 | 8 | |
| Berge Terence M | VP-Corporate Controller | 1004 0.0032% | $60,290.20 | 0 | 12 | |
| Ferrell John D. | Executive Vice President - HR | 702 0.0023% | $42,155.10 | 0 | 1 | |
| REMMELL ROBERT | director | 675 0.0022% | $40,533.75 | 0 | 1 | |
| STARR EUGENE | President-Electrosurgery | 572 0.0018% | $34,348.60 | 0 | 2 | |
| WOODARD GERALD G | PRESIDENT LINVATEC | 0 0% | $0 | 0 | 6 | |
| MANDIA STEPHEN | director | 1 0% | $32.78 | 0 | 6 | |
| POMILIO LUKE A | 0 0% | $0 | 0 | 22 | ||
| Johnson David Allen | VP - Global Operations | 0 0% | $0 | 0 | 5 | |
| Garner Todd W | Executive Vice President & CFO | 0 0% | $0 | 0 | 9 |
CNMD Institutional Investors: Active Positions
| Increased Positions | 149 | +45.43% | 4M | +12.63% |
| Decreased Positions | 143 | -43.6% | 2M | -6.24% |
| New Positions | 51 | New | 3M | New |
| Sold Out Positions | 41 | Sold Out | 817,351 | Sold Out |
| Total Postitions | 334 | +1.83% | 36M | +6.4% |
CNMD Ownership Change vs Market
Institutional Investor Ownership
| Blackrock, Inc. | $283,970.00 | 15.88% | 4.92M | -13,687 | -0.28% | 2025-03-31 |
| Vanguard Group Inc | $206,173.00 | 11.53% | 3.57M | +44,777 | +1.27% | 2024-12-31 |
| Earnest Partners Llc | $162,091.00 | 9.07% | 2.81M | +25,876 | +0.93% | 2024-12-31 |
| Capital Research Global Investors | $90,971.00 | 5.09% | 1.58M | +32,630 | +2.11% | 2024-12-31 |
| State Street Corp | $78,356.00 | 4.38% | 1.36M | +51,212 | +3.92% | 2024-12-31 |
| Champlain Investment Partners, Llc | $75,016.00 | 4.2% | 1.3M | -67,092 | -4.91% | 2024-12-31 |
| Bank Of America Corp /De/ | $71,909.00 | 4.02% | 1.25M | -123,517 | -9.01% | 2024-12-31 |
| Silvercrest Asset Management Group Llc | $57,721.00 | 3.23% | 1M | +1M | New | 2024-12-31 |
| Sei Investments Co | $53,667.00 | 3% | 930,426 | +59,703 | +6.86% | 2024-12-31 |
| Macquarie Group Ltd | $53,621.00 | 3% | 929,636 | -5,961 | -0.64% | 2024-12-31 |